HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030

Comments · 101 Views

Development initiatives of HPAPIs and cytotoxic drugs are generally very demanding, both in terms of experience and capital investment. Most companies generally lack the necessary resources to meet the aforementioned requirements and are unable to set up dedicated HPAPI and cytotoxic drug

The USD 25 billion (by 2030) financial opportunity within the HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020- 2030 has been analyzed across the following segments:

Type of Product

  • HPAPIs
  • Highly Potent Finished Dosage Forms

Company Size

  • Small-sized
  • Mid-sized
  • Large / Very Large

Scale of Operation

  • Preclinical / Clinical
  • Commercial

Type of Pharmacological Molecule

  • Small Molecules
  • Biologics

Type of Highly Potent Finished Dosage Form

  • Injectables
  • Oral Solids
  • Creams
  • Others

Key geographical regions

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

For more information, please visit https://www.rootsanalysis.com/reports/299/request-sample.html

The “HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030” report features the following companies, which we identified to be key players in this domain:  

  • AbbVie Contract Manufacturing
  • Catalent
  • Evonik
  • Formosa Laboratories
  • Intas
  • Lonza
  • MabPlex
  • Pfizer CentreOne

Table of Contents

  1. Preface
  2. Executive Summary
  3. Introduction
  4. Market Landscape
  5. Company Competitive Analysis
  6. HPAPI and Cytotoxic Drugs Contract Manufacturers based in North America: Company Profiles
  7. HPAPI and Cytotoxic Drugs Contract Manufacturers based in Europe: Company Profiles
  8. HPAPI and Cytotoxic Drugs Contract Manufacturers based in Asia Pacific: Company Profiles
  9. Partnerships and Collaborations
  10. Recent Expansions
  11. Capacity Analysis
  12. Market Sizing and Opportunity Analysis
  13. Case-In-Point: Contract Manufacturing of Antibody Drug Conjugates
  14. Concluding Remarks
  15. Executive Insights
  16. Appendix 1: Tabulated Data
  17. Appendix 2: List of Companies and Organizations

Get Customized Report:


About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415